2015, Number 4
<< Back Next >>
Rev Cub Oftal 2015; 28 (4)
Syphilitic uveitis associated with the human immunodeficiency virus
Ambou FI, Benítez CM, Vilches LD, Ramos BL, Muñoz GB, Sibila GM
Language: Spanish
References: 26
Page: 374-380
PDF size: 88.06 Kb.
ABSTRACT
Syphilis is a chronic and multisystemic infection, caused by
Treponema Pallidum spirochetes. The ocular manifestations of syphilis are varied and may affect all the ocular structures, being uveítis the most common type of ocular effect. It can appear in the secondary, latent or tertiary phase and in a bilateral form in 50% of the cases, it may be associated with the human immunodeficiency virus. Since the introduction
of the highly active antiretroviral therapy, AIDS-associated mortality lowered whereas
the incidence of syphilis and other sexually transmitted diseases increased as a result of the rise of homosexual population. Due to their great variety in the ways of
presentation, syphilis is known as the great simulator and is part of the differential diagnosis of any kind of uveitis. Here is the case of a 64 year-old male patient who went to the Emergency Service, because he felt blurred vision in his right eye for 45
days approximately. Additionally, he presented with eye reddening, pain and discomfort when looking into the light; finally he was diagnosed as human
immunodeficiency virus -associated syphilitic uveitis case.
REFERENCES
Aldave AJ, King JA, Cunningham ET Jr. Ocular syphilis. Curr Opin Ophthalmol. 2001;12(6):433-41.
Amaratunge BC, Hall AJ. Ocular syphilis in Victoria: four new cases and a brief discussion of the current Victorian experience. Clin Experiment Ophthalmol. 2008;36(2):192-4.
Margo CE, Hamed LM. Ocular syphilis. Surv Ophthalmol. 1992;37(3):203-20.
Doris JP, Saha K, Jones NP, Sukthankar A. Ocular syphilis: the new epidemic. Eye. 2006;20(6):703-5.
Gaudio PA. Update on ocular syphilis. Curr Opin Ophthalmol. 2006;17(6):562-6.
Kent ME, Romanelli F. Reexamining syphilis: an update on epidemiology, clinical manifestations and management. Ann Pharmacother. 2008;42(2):226-36.
Chhablani JK, Biswas J, Sudharshan S. Panuveitis as a manifestation of ocular syphilis leading to HIV diagnosis. Oman J Ophthalmol. 2010;3(1):29-31.
Amaratunge BC, Camuglia JE, Hall AJ. Syphilitic uveitis: a review of clinical manifestations and treatment outcomes of syphilitic uveitis in human immunodeficiency virus. Positive and negative patients. Clin Experiment Ophthalmol. 2010;38(1):68-74.
Ng DS, Wong IY, Chan CW. Reemergence of syphilitic uveitis masquerading as other diseases: a report of two cases. Case Rep Ophthalmol. 2011;2(2):266-72.
Hook EW, Peeling RW. Syphilis control: a continuing challenge. N Engl J Med. 2004;351(2):122-4.
Browning DJ. Posterior segment manifestations of active ocular syphilis, their response to a neurosyphilis regimen of penicillin therapy, and the influence of human immunodeficiency virus status on response. Ophthalmology. 2000;107(11):2015-23.
Recent developments in syphilis epidemiology. CDR Wkly. 2003 [citado 9 de febrero de 2009];13(31):5-9. Disponible en: http://www.hpa.org.uk/cdr/archives/2003/cdr3103.pdf
Li JZ, Tucker JD, Lobo AM, Marra CM, Davis BT, Papaliodis GN, et al. Ocular syphilis among HIV. infected individuals. Clin Infect Dis. 2010;51(4):468-71.
Smith G, Holman RP. The prozone phenomenon with syphilis and HIV. Coinfection. South Med J. 2004;97(4):327-8.
Jurado RL, Campbell J, Martin PD. Prozone phenomenon in secondary syphilis: has its time arrived? Arch Intern Med. 1993;153(21):2496-8.
Kingston A, Vujevich J, Shapiro M, Chad M, Hivnor CM, Jukic DM, Hopkins JM, et al.Seronegative Secondary syphilis in 2 patients coinfected with human immunodeficiency virus. Arch Dermatol. 2005;141(4):431-3.
Tucker JD, Li JZ, Robbins GK, Davis BT, Lobo AM, Kunkel J, Papaliodis GN, et al. Ocular syphilis among HIV. infected patients: a systematic analysis of the literature. Sex Transm Infect. 2011;87(1):4-8.
Balba GP, Kumar PN, James AN, Malani A, Palestine AG, Welch JN, et al. Ocular syphilis in HIV. Positive patients receiving highly active antiretroviral therapy. Am J Med. 2006;119(5):448.
Seña AC, White BL, Sparling PF. Novel Treponema pallidum scrologic tests: a paradigm shift in syphilis screening for the 21 st century. Clin Infect Dis. 2010;51(6):700-8.
Shalaby IA, Dunn JP, Semba RD, Jabs DA. Syphilitic uveitis in human immunodeficiency virus. infected patients. Arch Ophthalmol. 1997;115(4):469-73.
Browning DJ. Posterior segment manifestations of active ocular syphilis, their response to a neurosyphilis regimen of penicillin therapy, and the influence of human immunodeficiency virus status on response. Ophthalmology. 2000; 107(11):2015-23.
Margo CE, Hamed LM. Ocular syphilis. Surv Ophthalmol. 1992;37(3):203-20.
Stoumbos VD, Klein ML. Syphilitic retinitis in a patient with acquired immunodeficiency syndrome. Related complex. Am J Ophthalmol. 1987;103(1):103-4.
Fu EX, Geraets RL, Dodds M, Echandi LV, Colombero D, McDonald HR, et al. Superficial retinal precipitates in patients with syphilitic retinitis. Retina. 2010;30(7):1135-43.
McLeish WM, Pulido JS, Holland S, Culbertson WW, Winward K. The ocular manifestations of syphilis in the human immunodeficiency virus type 1. Infected host. Ophthalmology. 1990;97(2):196-203.
Blocker ME, Levine WC, St Louis ME. HIV prevalence in patients with syphilis. EE.UU.: Sex Transm Dis. 2000;27(1):53-9.